STOCKHOLM, SWEDEN，Mar. 26, 2021 -The weeklong ISU (International Skating Union) World Figure Skating Championships (the Championships), an Olympic qualification event, is held in Ericsson Globe arena in Stockholm, Sweden from 23rd to 28th of March. The world’s top figure skaters from around the world have travelled to Sweden to compete for the title of world champion in men's singles, ladies’ singles, pairs, and ice dance. The event is the largest sporting event in the country since COVID-...

SHENZHEN, Mar. 18, 2021/PRNewswire/ --MGI, a global life-science technology innovator, lends a hand to resource-restrained African countries in response to the surge of local COVID-19 cases. New COVID-19 variants have emerged in Africa causing growing concerns globally. In a recent study published in Nature, the scientists expressed fear that these new variants show less effects to the current vaccines, and reinfections may be more likely. The study also found that the South Africa varian...

SHENZHEN, Mar. 2, 2021 --WHO has called on many countries to “build and boost”genomic surveillance. MGI is actively joining hands with leading research collaborators contributing to the genomic surveillance in multiple countries.In March 2020, the Korea Institute of Basic Sciences RNA Research Center and Seoul National University released the high-definition mapping of the COVID-19 transcriptome and epigenetic transcriptome generated from MGI’s DNBSEQ-G50 platform. InGenomic Sequencing...

In response to the interim ruling by the Hong Kong High Court on 25th February 2021 regarding Illumina’s patent lawsuit against MGI, MGI makes the following statement: MGI welcomes the court’s decision not to issue an injunction. We respect the court’s judgement and will abide by the undertaking that we made to the court. It should be noted that we have initiated an antitrust lawsuit against Illumina in the United States as a result of its illegal acquisition of patents, and this lawsu...

MGI’s sequencing platform in the YUCEBIO’s lab SHENZHEN, China, Feb 24, 2021-- MGI’s ultra-high-throughput gene sequencer, DNBSEQ-T7, is installed in Yukang Medical Laboratory of YUCEBIO. YUCEBIO and MGI will be working with each other again after their cooperation in 2018 and 2019. In the cooperation, YUCEBIO will promote the development of clinical application of tumor immunodiagnosis and treatment based on the technical advantages of DNBSEQ-T7, and combined with its own advantages ...

In response to the rulings of the Patents Court within the High Court of Justice for England & Wales on 18th February 2021, MGI makes the following statement: We welcome the Court’s decision to give us the permission to appeal the judgment, and we intend to file its appeal with the Court of Appeal. As permitted by the Court, we will continue to supply sequencing reagents to our existing customers in the UK during the appeal period. Although MGI is appealing aspects of the judgement, i...